Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical EGCG for Radiodermatitis in Breast Cancer
NCT01481818Phase 2Unknown
- Sponsor
- Shandong Cancer Hospital
- Start
- Sep 2011
- Primary completion
- Jun 2022
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 2 trial of epigallocatechin gallate in radiation dermatitis, Radiation mucositis (RIM), sponsored by Shandong Cancer Hospital. Status: unknown.
02
Drugs
epigallocatechin gallate
03
Conditions
radiation dermatitisRadiation mucositis (RIM)
Beyond the preview
Go deeper on NCT01481818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481818.